3 Results for "

heme malignancies

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "heme malignancies" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P99934
CAS No.: 1820660-69-2
Synonyms: ABBV-621

Research Areas:  

Cancer

Eftozanermin alfa (ABBV-621) is a tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) agonist. Eftozanermin alfa is a fusion protein consisting of a mutant immunoglobulin G1-Fc linked to 2 single-chain trimers of TRAIL. Eftozanermin alfa induces apoptosis in tumor cells by activation of death receptors (DR4 receptor and DR5 receptor) with Kds of 780 nM and 635 nM. Eftozanermin alfa can be used for the research of multiple solid and heme malignancies .
loading...
    loading...
Cat. No.: HY-147831
CAS No.: 2851820-52-3
Purity:  99.64%
HR-19011 is an eIF2α phosphorylation activator targeting heme-regulated inhibitor HRI (EIF2AK1). HR-19011 exhibits growth inhibitory activity against K562 cells with an IC50 value of 3.91 µM. HR-19011 inhibits the growth of hematologic malignancies by targeting HRI to activate the integrated stress response via the HRI-eIF2α-ATF4 axis. HR-19011 shows good safety in vivo. HR-19011 can be used for research on hematologic malignancies (leukemia) .
loading...
    loading...
Cat. No.: HY-125585
CAS No.: 1345458-66-3
Target:  

Syk

Research Areas:  

Others

Syk-IN-2 (Page 78; 35) is a spleen tyrosine kinase (Syk) inhibitor .
loading...
    loading...